位于杜塞尔多夫的德固赛公司高性能聚合物业务部宣布，自2005年11月1日起将把所有基于尼龙的产品(VESTAMID?, VESTOSINT?, VESTAMLET? 和 TROGAMID?)的价格提高5－9％。

对于VESTENAMER? polyoctenamer产品系列，价格会有平均12％的增长。

单体和合成C8和C12环状化学品的价格上升幅度将可高达30%。
 

该业务部门一直在努力用削减成本和优化整个供货链操作等方法抵消持续攀升的生产成本。然而主要与能源、运输和原材料相关的成本增长幅度使得提价终于在所难免，这样才可以确保高性能聚合物部门在将来得以持续发展。

目前与高性能聚合物有长期合同的客户在合同终止期前不受此价格增长的影响。

The High Performance Polymers Business Unit of Degussa AG, Düsseldorf, announces global price increases of 5 to 9% across the entire nylon-based product portfolio (VESTAMID?, VESTOSINT?, VESTAMLET? and TROGAMID?) effective November 1, 2005.
Regarding its VESTENAMER? polyoctenamer portfolio, prices will increase on average by 12%.Finally, the prices of monomers and chemicals for synthesis of the C8 and C12 ring family will increase up to 30%.
 The business unit has been permanently striving to offset dramatic and continuous rising costs with productivity measures involving both cost-cutting and process optimization programs along the whole supply chain. However, the extent of the cost increase, linked mainly to energy, transportation and raw materials, makes these price increases inevitable in order to enable High Performance Polymers to remain a sustainable partner in the future. Customers under current long-term contract agreements are not concerned by this price increases until the scheduled termination.

Degussa is the global market leader in specialty chemicals. Our innovative products and system solutions make an indispensable contribution to our customers' success, which we sum up by our claim "creating essentials". In fiscal 2004 Degussa's 45,000 employees worldwide generated sales of 11.2 billion euros and operating profits (EBIT) of 965 million euros.